JP Morgan Reiterates Overweight Rating on Exponent, Inc. (EXPO)
Rating Change JP Morgan analysts reiterated a Overweight rating on Exponent, Inc. (NASDAQ:EXPO) on July 31, 2026. Market Context Exponent, Inc.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change JP Morgan analysts reiterated a Overweight rating on Exponent, Inc. (NASDAQ:EXPO) on July 31, 2026. Market Context Exponent, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Hilton Grand Vacations Inc. (NYSE:HGV) on July 31, 2026. Market Context Hilton Grand Vacations Inc.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Hilton Grand Vacations Inc. (NYSE:HGV) on July 31, 2026. Market Context Hilton Grand Vacations Inc.
Read moreRating Change Ladenburg Thalmann analysts reiterated a Neutral rating on Regency Centers Corporation (NASDAQ:REGCO) on July 31, 2026. Market Context Regency Centers Corporation…
Read moreRating Change Goldman Sachs analysts reiterated a Buy rating on DLocal Limited (NASDAQ:DLO) on July 31, 2026. Market Context DLocal Limited operates in the Technology sector. The…
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Chemed Corporation (NYSE:CHE) on July 31, 2026. Market Context Chemed Corporation operates in the Healthcare…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Kirby Corporation (NYSE:KEX) on July 31, 2026. Market Context Kirby Corporation operates in the Industrials sector. The…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Dolby Laboratories, Inc. (NYSE:DLB) on July 31, 2026. Market Context Dolby Laboratories, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Mizuho analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Ryan Specialty Holdings, Inc. (NYSE:RYAN) on July 31, 2026. Market Context Ryan Specialty Holdings, Inc.
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Prosperity Bancshares, Inc. (NYSE:PB) on July 31, 2026. Market Context Prosperity Bancshares, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Prosperity Bancshares, Inc. (NYSE:PB) on July 31, 2026. Market Context Prosperity Bancshares, Inc.
Read moreRating Change BTIG analysts reiterated a Buy rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read moreRating Change Mizuho analysts reiterated a Outperform rating on Guardant Health, Inc. (NASDAQ:GH) on July 31, 2026. Market Context Guardant Health, Inc.
Read more